Literature DB >> 9504338

Molecular epidemiology of American trypanosomiasis in Brazil based on dimorphisms of rRNA and mini-exon gene sequences.

B Zingales1, R P Souto, R H Mangia, C V Lisboa, D A Campbell, J R Coura, A Jansen, O Fernandes.   

Abstract

American trypanosomiasis is transmitted in nature via a sylvatic cycle, where Trypanosoma cruzi interacts with wild triatomines and mammalian reservoirs, or via a domestic cycle where the parasite comes into contact with humans through domiciliated triatomines. The pool of T. cruzi isolates consists of sub-populations presenting a broad genetic diversity. In contrast to the heterogeneity suggested by isoenzyme analysis, PCR amplification of sequences from the 24S alpha rRNA gene and from the non-transcribed spacer of the mini-exon gene indicated dimorphism among T. cruzi isolates, which enabled the definition of two major parasite lineages. In the present study, 157 T. cruzi isolates obtained from humans, triatomines and sylvatic mammalian reservoirs from 12 Brazilian states were analysed by the 24S alpha RNA and mini-exon typing approaches. The stocks were classified into the two proposed lineages and according to the domestic or sylvatic cycle of the parasite. Data presented provide evidence for a strong association of T. cruzi lineage 1 with the domestic cycle, while in the sylvatic cycle both lineages circulate equally. Molecular typing of human parasite isolates from three well-characterised endemic regions of Chagas disease (Minas Gerais, Paraiba and Piaui) and from Amazonas State, where T. cruzi is enzootic, suggests that in some endemic areas in Brazil there is a preferential linkage between both cycles mediated by lineage-1 stocks.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504338     DOI: 10.1016/s0020-7519(97)00178-1

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  29 in total

1.  Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Variability of kinetoplast DNA gene signatures of Trypanosoma cruzi II strains from patients with different clinical forms of Chagas' disease in Brazil.

Authors:  Eliane Lages-Silva; Luis Eduardo Ramírez; André Luiz Pedrosa; Eduardo Crema; Lúcia Maria da Cunha Galvão; Sérgio Danilo Junho Pena; Andrea Mara Macedo; Egler Chiari
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  PCR-based screening and lineage identification of Trypanosoma cruzi directly from faecal samples of triatomine bugs from northwestern Argentina.

Authors:  P L Marcet; T Duffy; M V Cardinal; J M Burgos; M A Lauricella; M J Levin; U Kitron; R E Gürtler; A G Schijman
Journal:  Parasitology       Date:  2006-01       Impact factor: 3.234

4.  Evidence of Trypanosoma cruzi II infection in Colombian chagasic patients.

Authors:  German Zafra; Julio Cesar Mantilla; Helder Magno Valadares; Andrea Mara Macedo; Clara Isabel González
Journal:  Parasitol Res       Date:  2008-06-04       Impact factor: 2.289

5.  Surveillance of Chagas disease among at-risk blood donors in Italy: preliminary results from Umberto I Polyclinic in Rome.

Authors:  Simona Gabrielli; Gabriella Girelli; Francesco Vaia; Mariella Santonicola; Azis Fakeri; Gabriella Cancrini
Journal:  Blood Transfus       Date:  2013-10-02       Impact factor: 3.443

6.  Two hybridization events define the population structure of Trypanosoma cruzi.

Authors:  Scott J Westenberger; Christian Barnabé; David A Campbell; Nancy R Sturm
Journal:  Genetics       Date:  2005-07-05       Impact factor: 4.562

7.  Microsatellite marker analysis shows differentiation among Trypanosoma cruzi populations of peripheral blood and dejections of Triatoma infestans fed on the same chronic chagasic patients : microsatellite marker analysis and T. cruzi.

Authors:  Juan Venegas; Sandra Miranda; William Coñoepan; Sergio Pîchuantes; María Isabel Jercic; Christian González; Marta Gajardo; Werner Apt; Arturo Arribada; Gittith Sánchez
Journal:  Parasitol Res       Date:  2010-06-29       Impact factor: 2.289

8.  Lineage analysis of circulating Trypanosoma cruzi parasites and their association with clinical forms of Chagas disease in Bolivia.

Authors:  Ramona del Puerto; Juan Eiki Nishizawa; Mihoko Kikuchi; Naomi Iihoshi; Yelin Roca; Cinthia Avilas; Alberto Gianella; Javier Lora; Freddy Udalrico Gutierrez Velarde; Luis Alberto Renjel; Sachio Miura; Hiroo Higo; Norihiro Komiya; Koji Maemura; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2010-05-18

9.  Probing population dynamics of Trypanosoma cruzi during progression of the chronic phase in chagasic patients.

Authors:  Daniella Alchaar D'Avila; Andréa Mara Macedo; Helder Magno Silva Valadares; Eliane Dias Gontijo; Ana Maria de Castro; Carlos Renato Machado; Egler Chiari; Lúcia Maria Cunha Galvão
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

10.  Molecular characterization of Trypanosoma cruzi sylvatic isolates from Rio de Janeiro, Brazil.

Authors:  Jacenir R Santos-Mallet; Cristina S Silva; Suzete A O Gomes; Daise L Oliveira; Cristina L Santos; Daniele M Sousa; Nadja L Pinheiro; Angela C V Junqueira; Teresa Cristina M Gonçalves
Journal:  Parasitol Res       Date:  2008-07-12       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.